Related Experiment Videos
Future delivery systems for apomorphine in patients with Parkinson's disease
T van Laar1, R Van der Geest, M Danhof
1Department of Neurology, Leiden University, The Netherlands.
Advances in Neurology
|July 20, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Feasibility of a Pharmabuddy Care Service for patients with Parkinson's disease.
BMC health services research·2024
Grasping the big picture: impact analysis of screening tools for timely referral for device-aided therapies.
Journal of neural transmission (Vienna, Austria : 1996)·2024
ASURE Clinical Trial Protocol: A Randomized, Placebo-Controlled, Proof-of-Concept Study Aiming to Evaluate Safety and Target Engagement following Administration of TW001 in Early Alzheimer's Disease Patients.
The journal of prevention of Alzheimer's disease·2023
Intermuscular coherence as a biomarker of subthalamic nucleus deep brain stimulation efficacy in Parkinson's disease.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2022
Radiation of parotid or submandibular glands is effective for drooling in patients with parkinsonism; a randomised double-blind placebo-controlled trial.
Clinical parkinsonism & related disorders·2022
Behavior therapy: other interventions for tic disorders.
Advances in neurology·2006
Treatment of aggression in Tourette syndrome.
Advances in neurology·2006
Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.
Advances in neurology·2006
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
Advances in neurology·2006
Preclinical models relevant to Tourette syndrome.
Advances in neurology·2006
Exploring the Advances of AI in Drug Development.
Current pharmaceutical design·2026
Comprehensive Review on the Development and Challenges of Osmotically Activated Drug Delivery Systems.
Current pharmaceutical design·2026
A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Escalation Study for the Evaluation of the Safety, Tolerability, and Pharmacokinetics of Recombinant Human Plasma Gelsolin (rhu-pGSN) Following Intravenous Administration to Healthy Volunteers.
Clinical pharmacology in drug development·2026
Application of Model-Informed Approaches in Neuroscience Drug Development and Regulatory Decision-Making.
Journal of clinical pharmacology·2026
Advances in multimodal data integration for drug efficacy prediction: Methodological evolution and clinical translation.
Drug discoveries & therapeutics·2026